The mechanism of action of mesalamine is not fully understood, but appears to be a topical anti-inflammatory effect on colonic epithelial cells. Mucosal production of arachidonic acid metabolites, ...
Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — Older patients with Crohn’s disease were less likely to receive biologic agents and more than ...
PHILADELPHIA, Oct. 6 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP; Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced the results from a ...
Once-daily LIALDA with MMX technology contains the highest mesalamine dose per tablet (1.2 g), so patients can take as few as two tablets once daily. Other currently available mesalamines require ...
Credit: Shutterstock. The 35-year-old male from Hawaii maintained clinical remission with Lialda, a once-daily formulation of mesalamine, and infliximab. A switch in the oral formulation of mesalamine ...
Basingstoke, UK and Philadelphia, US – January 16, 2007 -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that the U.S. Food and Drug Administration (FDA) has approved LIALDA TM ...
May 26, 2006 (Los Angeles) — SPD476, a high-dose, timed-release mesalamine (5-aminosalicylic acid [ASA]) formulation, induces remission of mild to moderate ulcerative colitis (UC), according to ...
The price you pay for Canasa may depend on factors such as your dosage, whether you have health insurance, and the pharmacy you use. Financial assistance may be available to help you with the cost of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback